by Combat Cancer | Jul 7, 2023 | News
We are excited to announce the proposed BCG-Unresponsive Trial – Combat HIVEC HEAT – in partnership with Leicester University Clinical Trials Unit. This is a phase 3, multi-centre, single-arm interventional trial of HIVEC® with Medac mitomycin C + maintenance for...
by Combat Cancer | Jan 22, 2023 | Hyperthermia
In the first of three articles exploring the history of hyperthermia as a medical treatment, Johannesburg-based urologist Dr Steven Cornish delves back into antiquity to its origins and explores developments including thermal therapy combined with radiotherapy and...
by Combat Cancer | Dec 1, 2022 | News
Press release, 1 December 2022 Combat Medical is pleased to announce the results of the HIVEC I phase 3 randomised controlled trial, published in European Urology Oncology on 23 November 2022. As with this year’s HIVEC II publication, this short-term regimen shows...
by Combat Cancer | Aug 23, 2022 | The Medical Innovators Interview
The Medical Innovators Interview with Professor Brant Inman | July 2022 From superheated nanoparticles to intravesical therapy and barriers to change in bladder-cancer treatment – there’s plenty of food for thought in our July Medical Innovators interview, with...
by Combat Cancer | Aug 22, 2022 | News
Press release, 22 August 2022 Combat Medical is pleased to announce the results of the HIVEC® II trial, published in European Urology on 20 August 20221. It is one in a series of recent HIVEC® publications helping chemo-hyperthermia to find its place in the treatment...
Recent Comments